![]() |
Trials |
Phase 2 Study of Selinexor (KPT-330) in Patients With Recurrent Glioblastoma After Failure of Radiation and Temozolomide (KING)Cancer type: Glioblastoma Phase: II Principal Investigator: Mau-Sørensen Morten Country: DK Keywords: Denmark, Rigshospitalet, GBM, SINE, selexinor Status: Inclusion completed Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT01986348?term=KCP-330&rank=6 |